Jacques Himpens

Jacques Himpens

Auto-generated profile, based on publicly available information

Jacques Himpens

Centre Hospitalier Universitaire de Saint-Pierre, Brussels, Belgium

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2011 in Archives of Surgery
Verified
Journal Article
Closed access
PDF file
JHJacques Himpens
Jacques Himpens
GCGuy-Bernard Cadière
Guy-Bernard Cadière
MBMichel Bazi
Michel Bazi
MVMichael Vouche
Michael Vouche
BCBenjamin Cadière
Benjamin Cadière
GDGiovanni Dapri
Giovanni Dapri
Research from JAMA Surgery — Long-term Outcomes of Laparoscopic Adjustable Gastric Banding


4 August 2012 in Obesity Surgery
Verified
Journal Article
Closed access
PDF file
JHJacques Himpens
Jacques Himpens
AVAnneleen Verbrugghe
Anneleen Verbrugghe
GCGuy-Bernard Cadière
Guy-Bernard Cadière
WEWouter Everaerts
Wouter Everaerts
JGJan-Willem Greve
Jan-Willem Greve

19 September 2012 in Obesity Surgery
Verified
Journal Article
Closed access
PDF file
JHJacques Himpens
Jacques Himpens
LCLaia Coromina
Laia Coromina
AVAnneleen Verbrugghe
Anneleen Verbrugghe
GCGuy-Bernard Cadière
Guy-Bernard Cadière

12 June 2024 in Surgery for Obesity and Related Diseases
Verified
Journal Article
Open access
Maurizio De LucaMaurizio De Luca
Maurizio De Luca
SSScott Shikora
Scott Shikora
DEDan Eisenberg
Dan Eisenberg
LALuigi Angrisani
Luigi Angrisani
CPChetan Parmar
Chetan Parmar
SKShanu N. Kothari
Shanu N. Kothari
The 2022 American Society for Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) updated the indications for metabolic and bariatric surgery (MBS), replacing the previous guidelines established by the National Institutes of Health (NIH) over 30 years ago. The evidence supporting these updated guidelines has been strengthened to assist metabolic and bariatric surgeons, nutritionists, and other members of multidisciplinary teams (MDTs), as well as patients. This study aims to assess the level of evidence and the strength of recommendations compared to the previously published criteria.

23 February 2024 in BJA Open
Verified
Journal Article
Open access
MCMatthieu Clanet
Matthieu Clanet
KTKarim Touihri
Karim Touihri
CHCeline El Haddad
Celine El Haddad
NGNicolas Goldsztejn
Nicolas Goldsztejn
JHJacques Himpens
Jacques Himpens
ADAnne-Catherine Dandrifosse
Anne-Catherine Dandrifosse
The efficacy and safety of opioid-free anaesthesia during bariatric surgery remain debated, particularly when administering multimodal analgesia. As multimodal analgesia has become the standard of care in many centres, we aimed to determine if such a strategy coupled with either dexmedetomidine (opioid-free anaesthesia) or remifentanil with a morphine transition (opioid-based anaesthesia), would reduce postoperative morphine requirements and opioid-related adverse events. In this prospective double-blind study, 172 class III obese patients having laparoscopic gastric bypass surgery were randomly allocated to receive either sevoflurane–dexmedetomidine anaesthesia with a continuous infusion of lidocaine and ketamine (opioid-free group) or sevoflurane–remifentanil anaesthesia with a morphine transition (opioid-based group). Both groups received at anaesthesia induction a bolus of magnesium, lidocaine, ketamine, paracetamol, diclofenac, and dexamethasone. The primary outcome was 24-h postoperative morphine consumption. Secondary outcomes included postoperative quality of recovery (QoR40), incidence of hypoxaemia, bradycardia, and postoperative nausea and vomiting (PONV). Eighty-six patients were recruited in each group (predominantly women, 70% had obstructive sleep apnoea). There was no significant difference in postoperative morphine consumption (median [inter-quartile range]: 16 [13–26] vs 15 [10–24] mg, P=0.183). The QoR40 up to postoperative day 30 did not differ between groups, but PONV was less frequent in the opioid-free group (37% vs 59%, P=0.005). Hypoxaemia and bradycardia were not different between groups. During bariatric surgery, a multimodal opioid-free anaesthesia technique did not decrease postoperative morphine consumption when compared with a multimodal opioid-based strategy. Quality of recovery did not differ between groups although the incidence of PONV was less in the opioid-free group. NCT05004519.